Smoking and inflammatory diseases

Best Practice and Research: Clinical Rheumatology

Volumn 22, Issue 5, 2008, Pages 923-935

  Vittecoq, Olivier ^a   Lequerré, Thierry ^a   Goëb, Vincent ^a   Le Loët, Xavier ^a   Abdesselam, Tassadit Ait ^a   Klemmer, Nathalie ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

anti CCP; extra articular manifestations; lupus; PTPN22; rheumatoid arthritis; shared epitope; smoking

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA; EPITOPE; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

ALLELE; ANTIBODY PRODUCTION; CANCER RISK; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; ENVIRONMENT; EUROPE; GENE INTERACTION; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLAMMATORY DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SUBCUTANEOUS NODULE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS; SMOKING;

EID: 56349095868     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2008.09.011     Document Type: Review

References (57)

1. MacGregor A.J., Snieder H., Rigby A.S., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis and Rheumatism 43 (2000) 30-37
2. Jawaheer D., and Gregersen P.K. Rheumatoid arthritis. The genetic components. Rheumatic Diseases Clinics of North America 28 (2002) 1-15
3. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31 (1988) 315-324
4. Reckner-Olsson A., Skogh T., and Wingren G. Comorbidity and lifestyle, reproductive factors and environmental exposures associated with rheumatoïd arthritis. Annals of the Rheumatic Diseases 60 (2001) 934-939
5. Krishnan E., Sokka T., and Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Research & Therapy 5 (2003) 158-162
6. Criswell L.A., Merlino L.A., Cerhan J.R., et al. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. The American Journal of Medicine 112 (2002) 465-471
7. Karlson E.W., Lee I.M., Cook N.R., et al. A retrospective cohort study of cigarette smoking and risk of rheumatod arthritis in female health professionals. Arthritis and Rheumatism 42 (1999) 910-917
8. Costenbader K.H., Feskanich D., Mandl L.A., and Karlson W.K. Smoking intensity, duration and cessation and the risk of rheumatoid arthritis in women. The American Journal of Medicine 119 (2006) 503-511
9. Stolt P., Bengtsson C., Nordmark B., et al., and the other members of the EIRA study group. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study using incident cases. Annals of the Rheumatic Diseases 62 (2003) 835-841
10. Mattey D.L., Dawes P.T., Clarke S., et al. Relationship among the HLA-DRB1 shared epitope, smoking and rheumatoid factor production in rheumatoid arthritis. Arthritis and Rheumatism 47 (2002) 403-407
11. Lee H.S., Irigoyen P., Kern M., et al. Interaction between smoking, the shared epitope and anti-cyclic citrullinated peptide. A mixed picture in three large north American rheumatoid arthritis cohorts. Arthritis and Rheumatism 56 (2007) 1745-1753
12. Pedersen M., Jacobsen S., Klarlund M., et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Research & Therapy 8 (2006) R133
13. Klareskog L., Stolt P., Landberg K., et al. A new model for an etiology of rheumatoid arthritis. Smoking may trigger HLA-DR (Shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis and Rheumatism 54 (2006) 38-46
14. Michou L., Teixeira V.H., Pierlot C., et al. Association between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Annals of the Rheumatic Diseases 67 (2008) 466-470
15. Lee D.M., Phillips R., Hagan E.M., et al. Quantifying anti-CCP titer: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases (April 2008) (on line)
16. Verpoort K.N., Papendrecht-van der Voort E.A.M., van der Helm-van Mil A.H.M., et al. Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitopes alleles. Arthritis and Rheumatism 56 (2007) 2913-2918
17. Padyukov L., Silva C., Stolt P., et al. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis and Rheumatism 50 (2004) 3085-3092
18. Linn-Rasker S.P., van der Helm-van Mil A.H.M., van Gaalen F.A., et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Annals of the Rheumatic Diseases 65 (2006) 366-371
19. van der Helm-van Mil A.H.M., Verpoort K.N., Le Cessie S., et al. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis and Rheumatism 56 (2007) 425-432
20. Chang S.C., Costenhader K.H., Laden F., et al. Geographic variation and the risk of rheumatoid arthritis in women. [abstract]. Arthritis and Rheumatism 54 Suppl. 9 (2000) S349
21. Goëb V., Dieudé P., Daveau R., et al. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitopes alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Rheumatology (2008) (on line)
22. Costenbader K.H., Chang S.C., de Vivo I., et al. Genetic polymorphism in PTPN22, PADI-4 and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Research & Therapy 10 (2008) R52
23. Kokkonen H., Johansson M., Innala L., et al. The PTPN22 1858 C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern sweden. Arthritis Research & Therapy 9 (2007) R56
24. Källberg H., Padyakov L., Plenge R.M., et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22 and smoking in two subsets of rheumatoid arthritis. American Journal of Human Genetics 80 (2007) 867-875
25. Saag K.G., Cerhan J.R., Kolluri S., et al. Cigarette smoking and rheumatoid arthritis severity. Annals of the Rheumatic Diseases 56 (1997) 463-469
26. Turesson C., O'Fallon W.M., Xrowson C.S., et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Annals of the Rheumatic Diseases 62 (2003) 722-727
27. Mattey D.L., Hutchinson Dawes P.T., Nixon N.B., et al. Smoking and disease activity severity in rheumatoid arthritis:association with polymorphism at the Glutathione S-Transferase M1 locus. Arthritis and Rheumatism 46 (2002) 640-646
28. Manfredsdottir V.F., Vikingsdottir T., Jonsson T., et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology 45 (2006) 734-740
29. Westhoff G., Rau R., and Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse but they do not have more joint damage than nonsmokers of the same serological group. Rheumatology 47 (2008) 849-854
30. Finckh A., Dehler S., Costenhader K.H., and Gabay C. Cigarette smoking and radiographic progression in rheumatoid arthritis. Annals of the Rheumatic Diseases 66 (2007) 1066-1071
31. Harrison B.J., Silman A.J., Wiles N.J., et al. The association of cigarette smoking with disease outcome in patientsHi with early inflammatory polyarthritis. Arthritis and Rheumatism 44 (2001) 323-330
32. Wolfe F., and Zwillich S.H. The long-term outcome of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis and Rheumatism 41 (1999) 1072-1082
33. Nyhall-Wahlin B.M., Jacobsson L.T., Petersson I.F., Turesson C., and Barfot Study Group. Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis. Annals of the Rheumatic Diseases 65 (2006) 601-606
34. Mikuls T.R., Hughes L.B., Westfall A.O., et al. Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Annals of the Rheumatic Diseases (2008) (on line)
35. Kim S.K., Park S.H., Shin I.H., and Choe J.Y. Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. The Journal of Rheumatology 35 (2008) 995-1001
36. Gochuico B.R., Avila N.A., Chow C.K., et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Archives of Internal Medicine 168 (2008) 159-166
37. Farragher T.M., Goodson N.J., Naseem H., et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis and Rheumatism 58 (2008) 359-369
38. Mattey D.L., Thomson W., Ollier W.E., et al. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of follow-up from the early rheumatoid arthritis study. Arthritis and Rheumatism 56 (2007) 1408-1416
39. Hyrich K.L., Watson K.D., Silman A.J., Symmons D.P.M., and and the BSR Biologics Register. Rheumatology 45 (2006) 1558-1565
40. Klareskog L., Padyakov L., and Alfredsson L. Smoking as a trigger for inflammatory rheumatic diseases. Current Opinion in Rheumatology 19 (2007) 49-54
41. Ghaussy N.O., Sibbitt Jr. W., Bankhurst A.D., and Qualls C.R. Cigarette smoking and disease activity in systemic lupus erythematosus. The Journal of Rheumatology 30 (2003) 1215-1221
42. Freiman A., Bird G., Metelitsa A.I., et al. Cutaneous effects of smoking. Journal of Cutaneous Medicine and Surgery 8 (2004) 415-423
43. McAlindon T., Giannotta L., Taub N., et al. Environmental factors predicting nephritis in systemis lupus erythematosus. Annals of the Rheumatic Diseases 52 (1993) 720-724
44. Maurel A., Apovo M., Beuzard Y., et al. Effect of smoking on blood rheology. Journal des maladies vasculaires 22 (1997) 239-243
45. Verro P., Levine S.R., and Tietjen G.E. Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 29 (1998) 2245-2253
46. Sairam S., Baethge B.A., and McNearney T. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies. Clinical Rheumatology 22 (2003) 24-29
47. Freemer M.M., King Jr. T.E., and Criswell L.A. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Annals of the Rheumatic Diseases 65 (2006) 581-584
48. Wiencke J.K., Thurston S.W., Kelsey K.T., et al. Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. Journal of the National Cancer Institute 91 (1999) 614-619
49. Costenbader K.H., Kim D.J., Peerzada J., et al. Cigarette smoking and the risk of sustemic lupus erythematosus: a meta-analysis. Arthritis and Rheumatism 50 (2004) 849-857
50. Ignat G.P., Rat A.C., Sychra J.J., et al. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies. The Journal of Rheumatology 30 (2003) 1761-1769
51. Abu-Shakra M., Gladman D.D., and Urowitz M.B. Malignancy in systemic lupus erythematosus. Arthritis and Rheumatism 39 (1996) 1050-1054
52. Sultan S.M., Ioannou Y., and Isenberg D.A. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology 39 (2000) 1147-1152
53. Bernatsky S., Boivin J.F., Joseph L., et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis and Rheumatism 52 (2005) 1481-1490
54. Menon S., Snaith M.L., and Isenberg D.A. The association of malignancy with SLE: an analysis of 150 patients under long-term review. Lupus 2 (1993) 177-181
55. Rahman P., Gladman D.D., and Urowitz M.B. Smoking interferes with efficacy of antimalarial therapy in lupus. The Journal of Rheumatology 25 (1998) 1716-1719
56. Jewell M.L., and McCauliffe D.P. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. Journal of the American Academy of Dermatology 42 (2000) 983-987
57. Lardet D., Martin S., Truchetet F., et al. Effect of smoking on the effectiveness of antimalarial drugs on lesions of patients with lupus: assessment in a prospective study. La Revue de médecine interne 25 (2004) 786-791